Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03042468
Title Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

prostate adenocarcinoma

Therapies

lutetium Lu 177 vipivotide tetraxetan

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.